TITLE

Guidelines: New Lows for LDL Target Levels

AUTHOR(S)
Mitka, Mike
PUB. DATE
August 2004
SOURCE
JAMA: Journal of the American Medical Association;8/25/2004, Vol. 292 Issue 8, p911
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Reports on an update of key cholesterol level guidelines. How the new guidelines further reduce the safe level of LDL-C or bad cholesterol for all patients; Determination of the National Cholesterol Education Program that patients at risk for heart attacks need to lower their LDL further than previously believed; Definition of patients who are considered high risk and very high risk; Finding of the research that more people probably need to be taking statins as a precaution; How exercise and diet can reduce the number by 30% without medication; Suggestion of acceptable levels for low and moderate risk patients; Ongoing research which may again reduce the acceptable levels of bad cholesterol. INSETS: Old vs New: 001 Adult Treatment Panel III (ATPIII) Guidelines;Key Trial Findings.
ACCESSION #
14228025

 

Related Articles

  • Serum cholesterol as a risk factor for coronary heart disease revisited. Rossouw, J. E. // South African Journal of Clinical Nutrition;2015, Vol. 28 Issue 1, p34 

    The biology of lipoproteins and lipoprotein particles as mediators of atherosclerosis has been documented extensively. Numerous prospective epidemiological studies have shown a robust relationship between low-density lipoprotein (LDL) cholesterol, or particles bearing apolipoprotein B, and...

  • LDL cholesterol.  // Mayo Clinic Health Letter;May2011, Vol. 29 Issue 5, p1 

    The article discusses new studies on mitigating low-density lipoprotein (LDL) cholesterol levels. It states that statin drugs have been used to break down LDL into smaller particles as a means of mitigating heart disease, as well as atherosclerosis which can also impact the brain. New studies...

  • A 39-Year-Old Woman With Hypercholesterolemia. Mittleman, Murray A. // JAMA: Journal of the American Medical Association;7/19/2006, Vol. 296 Issue 3, p319 

    This article focuses on a conference between patient and doctor concerning the case of a 39-year-old African-American woman with hypercholesterolemia, well-controlled hypertension and a maternal history of breast cancer. Although her 10-year risk of coronary heart disease (CHD) is relatively low...

  • Taking statins.  // Mayo Clinic Health Letter;Nov2015, Vol. 33 Issue 11, p4 

    The article discusses joint guidelines from the American College of Cargiology and American Heart Association that can help streamline the assessment of who can benefit from taking a statin with respect to overall risk of heart attack and stroke. The guidelines suggest specific regimens of...

  • Benefits of long-term statin treatment.  // Australian Journal of Pharmacy;May2012, Vol. 93 Issue 1104, p92 

    The article reports on a study to examine the long-term effects of statin in lowering low-density lipoprotein (LDL) cholesterol. A follow-up randomized trial was carried out on patients who are at high risk of vascular and non-vascular outcomes. The results concluded large reduction in chances...

  • Education: Viewpoint - Statins in ischaemic stroke. Sever, Peter; Poulter, Neil // GP: General Practitioner;5/12/2014, p12 

    The article argues on the role of statins in ischaemic stroke prevention. Topics discussed include guidelines from Europe and the U.S. on statins as secondary treatment which targets low-density lipoprotein (LDL) cholesterol, the implications of these guidelines to statin therapy in Great...

  • PCSK9 Inhibitors: Are We on the Verge of a Breakthrough? Yang, E. // Clinical Pharmacology & Therapeutics;Dec2015, Vol. 98 Issue 6, p590 

    Statins are first-line therapy for lowering cholesterol and reducing cardiovascular events. A significant need for new lipid-modifying therapies remains for patients unable to tolerate statins or achieve guideline-based cholesterol targets. Proprotein convertase subtilisin/kexin type 9 (PCSK9)...

  • Are treatment targets for hypercholesterolemia evidence based? Systematic review and meta-analysis of randomised controlled trials. Y Lebenthal // Archives of Disease in Childhood;Sep2010, Vol. 95 Issue 9, p673 

    OBJECTIVE: Search for evidence supporting target age, level of intervention and target values for low-density lipoprotein (LDL) cholesterol levels in children with familial hypercholesterolemia. DESIGN: Systematic review and meta-analysis. PubMed, Medline, CINAHL and Cochrane Reviews databases...

  • Cut Your Heart Attack Risk in Half. Quinn, Joan // Prevention;Nov2001, Vol. 53 Issue 11, p48 

    Focuses on ways to predict and reduce heart attack risk from high cholesterol. INSET: The Risk Factors.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics